A preliminary study of brain metabolism in treatment-resistant depression before and after treatment with olanzapine-fluoxetine combination
José V. Pardo, Sohail A. Sheikh, Graeme Schwindt, Joel T. Lee, David E. Adson, Barry R. Rittberg, Faruk S. Abuzzahab
This study examines cerebral metabolism changes in treatment-resistant depression patients before and after olanzapine-fluoxetine combination treatment, finding metabolism decreases in the amygdala correlate with clinical response.
PLoS ONE · Jan 13, 2020Peer-reviewedNeuroscience